Professionals must now witness the consumption of hydromorphone and other safer supply prescriptions—and the sudden change in rules, with little accompanying guidance has made for a lot of extra work.
Leaders from major U.S. pharmacy banners and associations met with their Canadian counterparts in Toronto this past week in an effort to share experiences, wisdom and lessons learned.
After delaying a decision on their regulatory stance on PPNs in December, the OCP has once again deferred the decision to wait for more clarity on the government's approach.